Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Laminin subunit gamma-1 (LAMC1) is a critical extracellular matrix glycoprotein that is an essential noncollagenous constituent of basement membranes. Laminins are heterotrimeric proteins comprised of alpha, beta, and gamma chains; LAMC1 encodes the gamma-1 chain, which is indispensable for the assembly and function of these networks. Laminin gamma-1 facilitates cell adhesion, migration, and organization into tissues, playing a vital role in tissue integrity and development, particularly during embryogenesis. Dysregulation or mutation of LAMC1 leads to a spectrum of diseases, including congenital myasthenic syndromes, junctional epidermolysis bullosa, and aberrant cancer cell spread and invasion, making it a relevant target and biomarker for therapeutic investigation. The protein functions by interacting with other basement membrane components, such as nidogen, and its proper expression is essential for organogenesis and maintenance of epithelial tissue architecture.
Modulation of LAMC1 gene expression via microRNAs leading to reduced cell adhesion, migration, and invasion (cancer therapeutic approach)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Laminin subunit gamma-1 (LAMC1).